Position in ONC
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$2,275,087
-$220,408 QoQ
Shares Held
7,661
-6.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ONC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Crossmark Global Holdings, Inc. holds $39,668,975 across 33 Biotechnology names. ONC ranks #5 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
83,415 | $7,851,019 | |
| 2 | ARGX |
Argenx SE
|
8,668 | $6,329,807 | |
| 3 | EXEL |
Exelixis, Inc.
|
79,230 | $3,398,174 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
51,090 | $2,886,074 | |
| 5 | ONC |
BeOne Medicines Ltd.
This page
|
7,661 | $2,275,087 | |
| 6 | ASND |
Ascendis Pharma A/S
|
7,783 | $1,780,205 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
6,534 | $1,235,252 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,704 | $1,207,444 |
All Filings in ONC
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,275,087 | 7,661 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $2,495,495 | 8,214 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $2,126,308 | 6,241 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,222,453 | 5,050 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $996,414 | 3,661 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $976,745 | 5,288 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $1,084,158 | 4,829 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $549,564 | 3,852 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $680,139 | 4,349 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $735,507 | 4,078 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $761,928 | 4,236 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $752,960 | 4,223 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $825,910 | 3,832 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $719,423 | 3,271 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $427,649 | 3,172 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $404,948 | 2,502 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $549,203 | 2,912 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $746,683 | 2,756 | Shares | Sole | 2022-01-10 | |
| 2021-09-30 | $688,248 | 1,896 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $578,618 | 1,686 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $503,323 | 1,446 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $451,148 | 1,746 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $534,497 | 1,866 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $332,714 | 1,766 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||